Tricaprilin

Tricaprilin

• CAS Number: 538-23-8
• UNSPSC Description: Tricaprilin (Trioctanoin) is an orally active and well tolerated ketogenic agent that safely induces ketosis. Tricaprilin restores brain electrical activity and metabolism to help counteract neuroinflammation in migraine. Tricaprilin is promising for research of migraine prevention and Alzheimer’s disease (AD). Tricaprilin is a pure C8 medium chain triglyceride (MCT)[1][2][3].
• Target Antigen: Endogenous Metabolite
• Type: Natural Products
• Related Pathways: Metabolic Enzyme/Protease
• Applications: Neuroscience-Neurodegeneration
• Field of Research: Inflammation/Immunology; Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/tricaprilin.html
• Purity: 98.0
• Solubility: DMSO : 41.67 mg/mL (ultrasonic)
• Smiles: CCCCCCCC(OCC(OC(CCCCCCC)=O)COC(CCCCCCC)=O)=O
• Molecular Weight: 470.68
• References & Citations: [1]Chow L, et al. Metabolic Mechanism in Migraine: Tricaprilin, a Ketogenic Agent[J].|[2]Walker J A, et al. Development of tricaprilin, a ketogenic drug for Alzheimer's disease[J].|[3]Walker J A, et al. Clinical development of tricaprilin, a ketogenic drug for Alzheimer's disease: Human/Human trials: Other[J]. Alzheimer's & Dementia, 2020, 16: e038787.
• Shipping Conditions: Room Temperature
• Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
• Clinical Information: Launched